Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-05-25

Clinical Trial Update: Human Umbilical Cord Mesenchymal Stem Cell Injection for the Treatment of Interstitial Lung Disease [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating injections of human umbilical cord mesenchymal stem cells for interstitial lung disease; the study is currently not yet recrui…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Human Umbilical Cord Mesenchymal Stem Cell Injection (umbilical cord mesenchymal stem cells)

Snippet

Sponsor: Shanghai Life Science & Technology | Conditions: Interstitial Lung Disease | Phase 1 | Status: NOT_YET_RECRUITING